MLKN · MillerKnoll, Inc. · Stock research

Current Thesis

A cheap cyclical furniture name that ran hard off a soft print. After Q4 FY2026 (reported 2026-06-24), MLKN closed the regular session at $17.29 (+7.66%) then faded 5.1% after-hours to $16.36 on weak forward metrics and has since squeezed to $21.42 (2026-07-04), roughly +24% and within 8% of the $23.18 52-week high. The tension for a momentum book: the price leg is extending while the underlying narrative decelerates. Orders fell 6.3% and backlog 10.8% YoY, one analyst cut the name to Hold, and CEO-transition uncertainty hangs over the FY2027 "operating discipline / debt reduction" reset. This is price momentum without narrative acceleration a stretched bounce into overhead resistance, not the pre-upgrade, accelerating-narrative setup momentum entries require.

Bullish and bearish views on MillerKnoll, Inc.

The model's bull view on MillerKnoll, Inc. (MLKN), in brief: Q4 FY2026 (2026-06-24): net sales $1.004B, +4.4% reported / +3.7% organic YoY, beat the ~$974M consensus; adj EPS $0.55 cleared the $0.51–$0.53 estimate range the P&L is executing better than feared on North America Contract plus Global Retail. The bear view: Leading indicators are rolling over: Q4 orders $972M, -6.3% reported / -6.9% organic; backlog $679M, -10.8% YoY (2026-06-24). Both cases follow in full.

Bull Case

• Q4 FY2026 (2026-06-24): net sales $1.004B, +4.4% reported / +3.7% organic YoY, beat the ~$974M consensus; adj EPS $0.55 cleared the $0.51–$0.53 estimate range the P&L is executing better than feared on North America Contract plus Global Retail.
• Valuation is genuinely low: forward P/E 10.6x on the FY2027 $1.85–$2.15 adj-EPS guide (midpoint $2.00), trailing 16.2x, and a 3.50% dividend ($0.75/yr) a rerating candidate if the cyclical rotation broadens.
• Cluster tailwind is live: MLKN traded up alongside Acuity (Q3 beat +17.1%), BlackBerry and Qualcomm in the 2026-06-25 industrials-gainers tape; a beta of 1.35 gives torque to the "cyclical-industrials-rotation" bid if the Fed eases.
• Thin sell-side coverage (1–3 analysts, median PT ~$31.50, range $25–$38) on a $1.46B-cap name means any new institutional initiation is unmodeled upside.

Bear Case

• Leading indicators are rolling over: Q4 orders $972M, -6.3% reported / -6.9% organic; backlog $679M, -10.8% YoY (2026-06-24). demand is flat-to-down, not accelerating.
• The headline "beat" masks a YoY decline: adj EPS $0.55 was down from $0.60 a year earlier (2026-06-24) the beat is versus a lowered bar, not growth.
• Post-print, one analyst downgraded to Hold citing lackluster growth, CEO-transition uncertainty, and the need for a "transformative strategy to reverse long-term share-price declines" the sell-side is drifting the wrong way while price runs.
• FY2027 guide midpoint ($2.00) merely matches consensus; the Q1 guide ($0.33–$0.39 vs $0.37 est; sales $928–968M vs $948M est) straddles estimates no upside inflection to fuel a fresh narrative.
• Price sits +24% above the 2026-06-24 close and is pressing the $23.18 52-week high on decelerating fundamentals the late-cycle "cheap and stretched into resistance" profile that mean-reverts.

Setup & Price Structure

• Last: $21.42 (2026-07-04); 52-week range $13.77–$23.18 trading in the top decile of its annual range.
• Post-earnings path: $17.29 close (2026-06-24) → $21.42 (2026-07-04), a near-vertical ~24% advance in roughly seven sessions; the rising 20-day sits near $18–19.
• Overhead resistance: the $23.18 52-week high is ~8% away and untested since the run began. A clean weekly close above it on expanding volume is the only condition that turns this extended tape into a chaseable breakout.
• Support / breakdown: $19 marks the rising 20-day and the mid-point of the post-earnings thrust; a weekly loss of it signals the bounce has failed.
• Character: beta 1.35, $1.46B cap, ~1.3M daily shares a low-float cyclical that travels fast both ways; the vertical advance carries squeeze mechanics rather than patient narrative accumulation.

Catalyst Calendar (next 30 days)

• ~2026-07-28/29 (est.): FOMC decision the primary swing factor for a beta-1.35, rate-sensitive housing/office cyclical; a dovish signal extends the rotation, a hawkish hold pressures the group.
• No company print in-window: Q1 FY2027 earnings land ~late September 2026 (est.), following the June 24 Q4 cadence the next company binary is more than 30 days out.
• Quarterly dividend (~$0.1875/sh; $0.75 annualized) declaration typically accompanies the print no fresh yield catalyst before the Q1 report.

Elapsed catalysts

• Undated overhang: CEO-transition news flagged on the 2026-06-24 call can surface any session and reset the FY2027 turnaround story in either direction. _(passed 21d ago)_

What Would Change Our Mind

• A weekly close above $23.18 (new 52-week high) on above-average volume, with the industrials-rotation cohort still leading, flips this from stretched fade to a momentum breakout worth a small probe.
• An order/backlog inflection on the next print orders back to YoY growth, backlog stabilizing would convert the cheap multiple from value-trap into a real cyclical-recovery narrative.
• A credible CEO appointment paired with concrete margin/debt targets could give the thin analyst bench a reason to re-rate coverage higher.
• Conversely, a weekly close below $19 (loss of the rising 20-day and the post-earnings thrust mid-point) confirms the bounce is spent and the decelerating orders/backlog data is setting the direction.

Correlation Notes

• Moves with the cyclical-industrials-rotation cohort Acuity (AYI) and the broader office/commercial-furnishings and building-products complex; the 2026-06-25 tape lifted MLKN alongside AYI, BB and QCOM as a risk-on industrials basket.
• Rate-sensitive: high beta (1.35) to real yields and the housing/CRE cycle it tracks homebuilder and office-REIT sentiment more closely than the S&P.
• Idiosyncratic overhangs (CEO transition, order/backlog trajectory) can decouple it from the group on stock-specific headlines.